DUK
60
-2
CRM
40
3
HRB
52
2
FIS
77
2
LNC
60
7
MCK
75
-2
GLW
55
3
HD
44
4
GS
58
-7
TGT
44
4
NEM
46
-3
JPM
67
5
PCG
64
2
DNB
62
12
MDT
53
-3
KHC
29
-5
PFG
52
13
CFG
62
2
D
25
-3
COF
64
2
DUK
60
-2
CRM
40
3
HRB
52
2
FIS
77
2
LNC
60
7
MCK
75
-2
GLW
55
3
HD
44
4
GS
58
-7
TGT
44
4
NEM
46
-3
JPM
67
5
PCG
64
2
DNB
62
12
MDT
53
-3
KHC
29
-5
PFG
52
13
CFG
62
2
D
25
-3
COF
64
2
Financhill
Back

Office Properties Income Trust Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
19

OPI
Office Properties Income Trust

Last Price:
$0.56
Seasonality Move:
0.86%
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$280.77
Seasonality Move:
3.3%
Sell
19
Office Properties Income Trust (OPI) is a Sell

Is Office Properties Income Trust a Buy, Sell or Hold?

  • The current Office Properties Income Trust [OPI] share price is $0.59. The Score for OPI is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • OPI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

OPI Stock Price Chart

What is Office Properties Income Trust's stock price today?

  • The Office Properties Income Trust share price today is $0.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPI is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

OPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 29.19 Sell
Chaikin Money Flow: 151920 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.72 - 0.94) Sell
Bollinger Bands (100): (0.8 - 1.42) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

OPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.69 Sell
20-day SMA: 0.81 Sell
50-day SMA: 0.88 Sell
200-day SMA: 1.67 Sell
8-day EMA: 0.68 Sell
20-day EMA: 0.78 Sell
50-day EMA: 0.91 Sell
200-day EMA: 1.77 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

Office Properties Income Trust Earnings Growth & OPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.51 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Office Properties Income Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):